Monthly reportZAMRA
Zambia Medicines Regulatory Authority — February 2026
What this register recorded from ZAMRA in February 2026, what other African authorities published in the same month that bears on it, and what we could not read in ZAMRA’s own notices. Every figure here is a count of published regulatory actions. None of it is a finding about Zambia Medicines Regulatory Authority.
What ZAMRA published
| Reference | Date | Country | Product | Batches | Action | Class | Source |
|---|---|---|---|---|---|---|---|
| DEA-ZM-2026-82905593 | 06 Feb 2026 | ZM | Cromohist Eye Drops Sodium Cromoglycate Opthalmic Solution USP 2%W/V Leeford Healthcare Limited India | LHE24038 | Recall | Class II | Tier 1 · Regulator-published |
| DEA-ZM-2026-58334872 | 09 Feb 2026 | ZM | Histergan-25 Promethazine Hydrochloride Tablets BP 25mg Mihika Pharmaceuticals, India | M23056 | Recall | Class II | Tier 1 · Regulator-published |
| DEA-ZM-2026-40339800 | 13 Feb 2026 | ZM | Sabulin (Salbutamol Tablets BP 4mg) Dawa Ltd , Kenya | 2310025 | Recall | Class I | Tier 1 · Regulator-published |
| DEA-ZM-2026-96364594 | 24 Feb 2026 | ZM | Mediquick Disposable Hypodermic Syringe 21g* 1.5 PH Healthcare Pvt.Ltd. India | E010822523 | Recall | Class I | Tier 1 · Regulator-published |
What other authorities published
What we could not read in ZAMRA’s notices
- 11 record(s) held from ZAMRA in total
- 1 carry no publication date we could read
- 0 name neither a batch nor a stated reason
- 0 name no manufacturer
- 1 are searchable and API-available but carry noindex, because they are too incomplete for a public URL
- 0 have no archived copy of the original notice
Correcting this
Anything on this page that is wrong about Zambia Medicines Regulatory Authority can be corrected by Zambia Medicines Regulatory Authority, and a record published by one of its officers carries verification tier 0 — the rank only the issuing regulator can create. Nothing else on this register does.